Related references
Note: Only part of the references are listed.GelJ - a tool for analyzing DNA fingerprint gel images
Jonathan Heras et al.
BMC BIOINFORMATICS (2015)
Inhibitory and Fungicidal Effects of Antifungal Drugs against Aspergillus Species in the Presence of Serum
Antigoni Elefanti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme
M. C. Arendrup et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India
Jagdish Chander et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2013)
Candida and invasive candidiasis: back to basics
C. S. -Y. Lim et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Risk Factors and Outcomes of Candidemia Caused by Biofilm-Forming Isolates in a Tertiary Care Hospital
Mario Tumbarello et al.
PLoS One (2012)
Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
Soak-In Jung et al.
ANNALS OF LABORATORY MEDICINE (2012)
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance
Sonia Silva et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Protein Binding: Do We Ever Learn?
Markus A. Zeitlinger et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009)
Michael A. Pfaller et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Changes in the incidence of candidaemia during 2000-2008 in a tertiary medical centre in northern Taiwan
L. -Y. Chen et al.
JOURNAL OF HOSPITAL INFECTION (2011)
Antifungal Susceptibility and Virulence Attributes of Bloodstream Isolates of Candida from Hong Kong and Finland
C. J. Seneviratne et al.
MYCOPATHOLOGIA (2011)
Proteinase, phospholipase, biofilm forming abilities and antifungal susceptibilities of Malaysian Candida isolates from blood cultures
Sun Tee Tay et al.
MEDICAL MYCOLOGY (2011)
Predictors of candidaemia caused by non-albicans Candida species: results of a population-based surveillance in Barcelona, Spain
D. Rodriguez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
In Vitro Biofilm Activity of Non-Candida albicans Candida Species
Sonia Silva et al.
CURRENT MICROBIOLOGY (2010)
Limited Role of Secreted Aspartyl Proteinases Sap1 to Sap6 in Candida albicans Virulence and Host Immune Response in Murine Hematogenously Disseminated Candidiasis
Alexandra Correia et al.
INFECTION AND IMMUNITY (2010)
Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms
C. J. Seneviratne et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Alicia I. Hidron et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Biofilm lifestyle of Candida: a mini review
C. J. Seneviratne et al.
ORAL DISEASES (2008)
Candida albicans versus non-albicans bloodstream infection in patients in a tertiary hospital: An analysis of microbiological data
George Samonis et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera
Nathan P. Wiederhold et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Pharmacology of systemic antifungal agents
Elizabeth S. Dodds Ashley et al.
CLINICAL INFECTIOUS DISEASES (2006)
In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin
RE Lewis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Hydrolytic enzymes as virulence factors of Candida albicans
M Schaller et al.
MYCOSES (2005)
Antimicrobial pharmacodynamics: Critical interactions of 'bug and drug'
GL Drusano
NATURE REVIEWS MICROBIOLOGY (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Iron and microbial infection
ME Schaible et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis
JR Naglik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2003)
Candida biofilms and their role in infection
LJ Douglas
TRENDS IN MICROBIOLOGY (2003)
Biofilm production by isolates of Candida species recovered from nonneutropenic patients:: Comparison of bloodstream isolates with isolates from other sources
JH Shin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
The direct cost and incidence of systemic fungal infections
LS Wilson et al.
VALUE IN HEALTH (2002)
Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate
I Bekersky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
G Ramage et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
International surveillance of bloodstream infections due to Candida species:: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Candida species exhibit differential in vitro hemolytic activities
G Luo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
Influence of human serum on antifungal pharmacodynamics with Candida albicans
GG Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
